NPR’s A Martinez asks Johns Hopkins University’s Mariana Socal about a pharmaceutical industry argument that Medicare price negotiations will cut profits and shortchange new drug research.
NPR’s A Martinez asks Johns Hopkins University’s Mariana Socal about a pharmaceutical industry argument that Medicare price negotiations will cut profits and shortchange new drug research.